 |
 |
|
 |
 |
|
   |
||
Idenix Pharmaceuticals to Present at 12th Annual BIO CEO & Investor Conference Idenix Pharmaceuticals Highlights Progress in Three HCV Programs Idenix Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
|
BIO CEO & Investor Conference 45th Annual Meeting of the European Association for the Study of the Liver
(EASL)
|
  |
